Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type II Diabetes Mellitus

NCT01868646 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Type II Diabetes Mellitus

Interventions

DRUG: Subetta
DRUG: Placebo

Sponsor

Materia Medica Holding